AstraZeneca

EU regulator backs wider use of AstraZeneca COVID drug

Sept 16 (Reuters) - Europe's medicines regulator has backed using AstraZeneca's preventative COVID-19 drug as a treatment for the disease and also endorsed its therapy against a major cause of…

Read More Here

AstraZeneca says EU regulator approves COVID shot as booster

May 23 (Reuters) - Drugmaker AstraZeneca said on Monday its COVID-19 vaccine, Vaxzevria, has been approved in the European Union by the bloc's drugs regulator as a third-dose booster in adults following…

Read More Here

European drugs regulator recommends AstraZeneca’s COVID drug

March 24 (Reuters) - The European Medicines Agency on Thursday authorised the use of AstraZeneca Plc's antibody drug for preventing COVID-19 infections in adults and adolescents over 12 years of age. The treatment…

Read More Here

AstraZeneca COVID drug neutralizes Omicron sub-variants in study

March 21 (Reuters) - AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent…

Read More Here

AstraZeneca says COVID vaccine demand high in Latam, Middle East, Asia

FRANKFURT, Feb 10 (Reuters) - Astrazeneca said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and Asia,…

Read More Here

Politicians who criticised AstraZeneca vaccine ‘probably killed hundreds of thousands’, says Oxford scientist

Scientists and politicians who expressed critical views of the AstraZeneca Covid vaccine “probably killed hundreds of thousands of people”, an Oxford professor has said. Professor Sir John Bell said critical…

Read More Here

EMA lists rare spinal condition as side effect of AstraZeneca’s COVID-19 shot

Jan 14 (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19…

Read More Here

UPDATED: AstraZeneca says higher antibody response against Omicron with booster dose

Jan 13 (Reuters) - AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron…

Read More Here

FACTBOX-Front runners in development of antibody drugs against COVID-19

AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest pharmaceutical companies to have developed COVID-19 treatments using a class of drugs called monoclonal antibodies, but the spread of the…

Read More Here

UPDATED: AstraZeneca shot third dose works against Omicron in study

Dec 23 (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford…

Read More Here

Nigeria destroys 1 million donated AstraZeneca vaccines with short shelf life

Nigeria destroyed more than a million doses of expired AstraZeneca vaccines in a bid to assure a wary public that they have been taken out of circulation. The destruction came…

Read More Here

Two-dose vaccines induce lower antibodies against Omicron, study finds

Dec 13 (Reuters) - Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected…

Read More Here

Scientists find trigger of rare blood clots with AstraZeneca vaccine

Scientists believe they have found "the trigger" that leads to extremely rare blood clots after the Oxford-AstraZeneca Covid vaccine. The team - in Cardiff and the US - have shown…

Read More Here

AstraZeneca COVID-19 antibody drug offers 83% protection over six months

Nov 18 (Reuters) - AstraZeneca on Thursday cemented its lead in bringing a preventative COVID-19 shot for the non-infected to market for people who do not respond well to vaccines,…

Read More Here

AstraZeneca vaccine turns profitable, drugmaker banking on new orders

Nov 12 (Reuters) - AstraZeneca is counting on new orders to move its COVID-19 vaccine to "modest profitability" after the shot made a small contribution to earnings in the third…

Read More Here

Vaccine combinations with different technologies may be best

Healthcare workers in France who got a first shot of AstraZeneca’s COVID-19 vaccine and then the Pfizer/BioNTech vaccine for their second shot showed stronger immune responses than those who had…

Read More Here

UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Oct 21 (Reuters) - The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on…

Read More Here

AstraZeneca COVID-19 vaccine shows 74% efficacy in large U.S. trial

AstraZeneca Plc's COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's…

Read More Here

Small study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix

A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines against COVID-19 has shown strong antibody growth in a majority of the study's participants, the…

Read More Here

UPDATED: EU fails to confirm if women, young adults at higher clot risk from AstraZeneca shot

The European Union's drugs regulator could not confirm from available data if women and young adults were at a higher risk of rare blood clots with low platelets after vaccination…

Read More Here

EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine

Europe's medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca's COVID-19 vaccine, regular safety updates from the watchdog showed. The European Medicines…

Read More Here

UPDATED: AstraZeneca, EU reach settlement on delivery of COVID-19 vaccine doses

The European Commission and AstraZeneca said on Friday they had reached a settlement on delivering remaining COVID-19 vaccine doses by the British drugmaker and also ended pending litigation in Brussels.…

Read More Here

Kosovo to destroy 133,000 AstraZeneca COVID-19 vaccines

The Kosovo government decided to destroy 133,000 AstraZeneca COVID-19 vaccines over their expired date of use as the country faces a sharp rise in the coronavirus death rate. The vaccines…

Read More Here

Small-scale study on mixing Sputnik V, AstraZeneca shows positive result – RDIF

Russian sovereign fund RDIF said on Friday it has achieved positive results from a small-scale study into the combined use of the AstraZeneca vaccine and the first component of the…

Read More Here

AstraZeneca’s antibody therapy prevents COVID-19 in study

AstraZeneca said on Friday its antibody therapy met the main goal of preventing COVID-19 disease in a late-stage study, putting the British drugmaker on track to potentially offer an alternative…

Read More Here

AstraZeneca’s CEO is the highest paid executive in the FTSE 100

AstraZeneca's CEO was the highest paid executive in the FTSE 100 in 2020, earning £15.45 million for his part in delivering a coronavirus vaccine that has been administered tens of millions of times already…

Read More Here

Poland to send 650,000 doses of AstraZeneca vaccine to Ukraine

WARSAW (Reuters) - Poland will send 650,000 doses of the AstraZeneca COVID-19 vaccine to Ukraine on Tuesday, the minister in charge of the Polish vaccination drive told state news agency…

Read More Here

Age restrictions on AstraZeneca shot have ended reports of rare clots -UK scientists

No new cases of a rare and severe blood clots following vaccination with AstraZeneca's COVID shot have been reported in Britain in recent weeks after a decision to restrict its…

Read More Here

Mixing Russia’s Sputnik V, AstraZeneca shots proves safe in small trial -RDIF

Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca’s shot revealed no serious side effects and no subsequent cases of coronavirus among volunteers, the Russian Direct…

Read More Here

AstraZeneca hopes to settle EU legal dispute in coming weeks

AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially ending a row that…

Read More Here

New Zealand gives provisional nod to AstraZeneca’s COVID-19 vaccine

New Zealand's health regulator Medsafe has granted provisional approval for the AstraZeneca COVID-19 vaccine for individuals 18 years of age and older, acting minister for COVID-19 response, Dr Ayesha Verrall,…

Read More Here

UPDATED: Rare blood clot cases not higher after AstraZeneca second dose

AstraZeneca's COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and…

Read More Here

EU regulator backs AstraZeneca drug for rare blood disorder in children

AstraZeneca said on Monday the European Medicines Agency (EMA) recommended approving a medicine from its U.S.-based Alexion unit for treating a rare, deadly blood disorder in children and adolescents aged…

Read More Here

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level – study

A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.…

Read More Here

Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds

Two doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study…

Read More Here

Brazil authorizes trials with 3rd dose of AstraZeneca COVID vaccine

Brazil's health regulator Anvisa said on Monday that it has approved trials with a third dose of the AstraZeneca vaccine against COVID-19. Anvisa said a third dose of the vaccine…

Read More Here

Thailand to mix Sinovac, AstraZeneca vaccines to increase protection

Thailand's immunisation strategy against the coronavirus will see a shot of AstraZeneca's viral vector vaccine administered after one dose of Sinovac's vaccine, its health minister said on Monday, The plan,…

Read More Here

UPDATED: Public Health England says AstraZeneca COVID shot gives 94% protection against death in over 65s

Two doses of the Oxford/AstraZeneca COVID-19 vaccine gives an estimated 94% protection against death from the disease in people over 65, Public Health England said on Thursday in a weekly…

Read More Here

Health Canada recommends people with rare blood condition not get AstraZeneca vaccine

Health Canada said it has recommended that people with a history of capillary leak syndrome not be inoculated with drugmaker AstraZeneca's COVID-19 vaccine. "Health Canada is updating the product monograph…

Read More Here

Immune response of AstraZeneca shot boosted by mixing dose schedule with Pfizer – study

LONDON (Reuters) - A mixed schedule of vaccines where a shot of Pfizer's COVID-19 vaccine is given four weeks after a AstraZeneca shot will produce better immune responses than giving…

Read More Here

Denmark continues exclusion of J&J, AstraZeneca COVID-19 vaccines

Danish health authorities said on Friday that COVID-19 vaccines from AstraZeneca and Johnson & Johnson would remain excluded from Denmark's vaccine roll-out following a review of new safety data. "The…

Read More Here

UPDATED: AstraZeneca says EU loses legal bid for more vaccine supplies by end-June

AstraZeneca said on Friday the European Union had lost a legal case against the pharmaceutical firm over the supply of COVID-19 vaccines, with a court in Brussels rejecting an EU…

Read More Here

EU drug regulator EMA records 415 cases of possible rare blood clotting

The EU drug regulator said on Thursday it has received reports of 415 possible cases of rare blood clotting with a low platelet count in the European Economic Area, out…

Read More Here

Australia recommends AstraZeneca COVID-19 vaccine only for people over 60

Australia will recommend AstraZeneca COVID-19 vaccines only for people aged 60 years and over, while Pfizer shots will be offered to others, Health Minister Greg Hunt said on Thursday. Australia…

Read More Here

14

Jun